Carol J. Wikstrand

Phase II Trial of Gefitinib in Recurrent Glioblastoma

Jeremy N. Rich, David A. Reardon, Terry Peery et al. · Journal of Clinical Oncology · 2003 · 736 citations · Full text

Medicine, Oncology, Pharmacology +17

Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting

John C. Sok, Francesca M Coppelli, Sufi M. Thomas et al. · Clinical Cancer Research · 2006 · 490 citations · Full text

Medicine, Oncology, Pharmacology +17

Heterogeneity of Genotypic and Phenotypic Characteristics of Fifteen Permanent Cell Lines Derived from Human Gliomas

Darell D. Bigner, Sandra H. Bigner, Jan Pontén et al. · Journal of Neuropathology & Experimental Neurology · 1981 · 485 citations

Medicine, Cell Biology, Oncology +12

Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.

Carol J. Wikstrand, Laura P. Hale, Surinder K. Batra et al. · PubMed · 1995 · 471 citations

Pharmacy, Cancer Biology, Oncology +17

Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.

Mario A. Bourdon, Carol J. Wikstrand, Heinz Furthmayr et al. · PubMed · 1983 · 375 citations

Medicine, Oncology, Pathology +14